590417-94-0 Usage
General Description
6-Bromo-1-methyl-1H-indazole is a chemical compound with the molecular formula C8H8BrN. It is a derivative of indazole, a heterocyclic aromatic organic compound. 6-Bromo-1-methyl-1H-indazole is used in chemical research and pharmaceutical development, particularly in the synthesis of new drugs and pharmaceutical compounds. It is also known for its potential applications in the field of medicinal chemistry, such as in the development of antiviral, antibacterial, and anticancer drugs. Additionally, 6-Bromo-1-methyl-1H-indazole is used as a building block in the creation of various molecules and can be utilized in the development of new materials and chemical processes. Overall, this compound has significant potential for various applications in the fields of chemistry and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 590417-94-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,9,0,4,1 and 7 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 590417-94:
(8*5)+(7*9)+(6*0)+(5*4)+(4*1)+(3*7)+(2*9)+(1*4)=170
170 % 10 = 0
So 590417-94-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H7BrN2/c1-11-8-4-7(9)3-2-6(8)5-10-11/h2-5H,1H3
590417-94-0Relevant articles and documents
COMPOUNDS AND USES THEREOF
-
Paragraph 1174, (2019/11/11)
The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES
-
Paragraph 000898, (2015/04/15)
Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).
AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLPROTEASES
-
Paragraph 0411, (2015/12/18)
The present invention provides a compound of Formula (I) or Formula (II): enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein. The compounds of Formula (I) and (II) are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions.
